Activist investor Ananym Capital Management is urging healthcare products distributor Henry Schein to refresh its board, cut ...
Henry Schein (NASDAQ:HSIC) rose 7.4% amid a report that an activist investor has taken a stake and is pushing for the dental ...
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
The most recent earnings report from Henry Schein, Inc. (NASDAQ:HSIC) was disappointing for shareholders. However, our analysis suggests that the soft headline numbers are getting counterbalanced by ...
Henry Schein (HSIC – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Michael ...
The 12-month price targets, analyzed by analysts, offer insights with an average target of $79.5, a high estimate of $82.00, ...
Despite modest sales growth, Henry Schein Inc (HSIC) boosts EPS guidance and expands its global e-commerce platform.
Analyst Erin Wright of Morgan Stanley maintained a Sell rating on Henry Schein (HSIC – Research Report), retaining the price target of ...